RxDoctor Payments Data

Douglas Wisch, MD

Hand Surgery · Torrington, CTNPI 1710931738

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.4%), education and speaking fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Kairos Surgical Inc at 31.5% of the total. Reporting peaked in 2022 at $3,221 and has fallen 76.6% since, to $753 in 2025.

$9,498in general payments, 2019–2025

Across 206 payments — averaging $46.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$3K
  • Arthrosurface Incorporated$2K
  • Smith+Nephew$1K
  • Endo Pharmaceuticals Inc.$587
  • Johnson & Johnson$505
  • Arthrex$278
  • plus $2K from 25 others

What the payments were for

  • Speaking & faculty fees$1,80019%
  • Travel & lodging$7948%
  • Food & beverage$4,50447%
  • Education$2,40025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,498 in reported general payments places this provider in the 85th percentile of 54 hand surgery providers in Connecticut.

See all hand surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$190,715
Medicare patients
330
Services billed
2,015

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amitriptyline Hcl18$245
Cephalexin21$42
Meloxicam11$10

Paid to pharmacies, not to this prescriber.

Other hand surgery in Torrington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →